Previous 10 | Next 10 |
2023-12-15 13:49:30 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Verrica Pharmaceuticals (NASDAQ: VRCA ) skyrocketed on Friday thanks to positive late-stage clinical trial results. Specifically, Verrica — along with its developme...
2023-12-15 13:25:40 ET Gainers: Getaround ( GETR ) +116% . Battalion Oil Corp ( BATL ) +82% . La Rosa Holdings Corp. ( LRHC ) +45% . Verrica Pharmaceuticals ( VRCA ) +37% . Bruush Oral Care ( BRSH ) +36% . NCS Multistage Hold...
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) is one of today's top gainers. The company's shares have moved 4.6% on the day to $3.52. Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The ...
2023-12-15 11:03:39 ET DENVER, Colo., Dec 15, 2023 ( www.247marketnews.com )- Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) has been marching higher, since reporting, this morning, that its development and commercialization partner, Torii Pharmaceutical, reported positive top-line results...
2023-12-15 10:47:09 ET More on Verrica Pharmaceuticals Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Verrica Pharmaceuticals Historical earnings data for Verrica Pharmaceuticals Financial informati...
2023-12-15 10:00:27 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Myomo, Aileron...
2023-12-15 08:46:33 ET Aurora Technology Acquisition ( ATAK ) +50% . Brilliant Acquisition ( BRLI ) +27% . Ikena Oncology ( IKNA ) +24% . SportsMap Tech Acquisition ( SMAP ) +14% . Pineapple Financial ( PAPL ) +1%...
WEST CHESTER, Pa., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that its developm...
WEST CHESTER, Pa., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced Ted White, Verric...
2023-11-09 09:57:02 ET Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Conference Call November 09, 2023 08:30 AM ET Company Participants Kevin Gardner - LifeSci Advisors Ted White - President & Chief Executive Officer\ Joe Bonaccorso - Chief Commercial ...
News, Short Squeeze, Breakout and More Instantly...
Verrica Pharmaceuticals Inc. Company Name:
VRCA Stock Symbol:
NASDAQ Market:
Verrica Pharmaceuticals Inc. Website:
- Dormer Labs has discontinued the sale of all cantharidin-containing products into the United States - YCANTH is the only commercially available, FDA approved therapy for molluscum contagiosum and is clinically proven to be safe and effective WEST CHESTER, Pa., July 01, 202...
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Pr...
Global pivotal Phase 3 clinical trial would be conducted jointly by Verrica and Torii Pharmaceutical; trial expected to begin in the 1 st half of 2025 Amendment should benefit both parties from a cost and time to market standpoint; funding structure is expected to have a min...